Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

COVID-19 Recovered Volunteer Research Participant Pool Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04359602
Recruitment Status : Recruiting
First Posted : April 24, 2020
Last Update Posted : May 4, 2020
Sponsor:
Information provided by (Responsible Party):
University of California, Los Angeles

Brief Summary:
This is a prospective observational registry of COVID-19 recovered patients who are no longer symptomatic. This Registry is intended to serve as a pool of individuals that can participate in studies associated with serological testing, characterization of immunity and immune response, vaccine development, and convalescent plasma donors.

Condition or disease
Recovered From COVID-19

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 10000 participants
Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration: 20 Years
Official Title: COVID-19 Recovered Volunteer Research Participant Pool Registry
Actual Study Start Date : April 8, 2020
Estimated Primary Completion Date : April 20, 2022
Estimated Study Completion Date : April 20, 2042



Primary Outcome Measures :
  1. Serological testing of COVID patients [ Time Frame: Up to 20 years ]
    Testing may be done on registry participants who agree to participate future studies

  2. Immune response [ Time Frame: Up to 20 years ]
    Testing may be done on registry participants who agree to participate future studies



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
People volunteering to share their information to become part of this research pool of COVID-19 recovered individuals will complete an online survey.
Criteria

Inclusion Criteria:

  • All patients seen the in emergency room, admitted patients, or seen in outpatient clinics that are:

    • Tested Positive for COVID-19 and recovered
    • Suspected to have COVID 19 and validated with serological testing
    • Suspected to have COVID 19 by symptoms, clinical course, and laboratory testing ruling out other respiratory viral disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04359602


Contacts
Layout table for location contacts
Contact: Antonia Petruse, MBA ClinicalResearchC19@mednet.ucla.edu

Locations
Layout table for location information
United States, California
Ronald Reagan UCLA Medical Center Recruiting
Los Angeles, California, United States, 90095
Sponsors and Collaborators
University of California, Los Angeles
Investigators
Layout table for investigator information
Principal Investigator: Arash Naeim, MD, PhD University of California, Los Angeles
Layout table for additonal information
Responsible Party: University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT04359602    
Other Study ID Numbers: 20-000625
First Posted: April 24, 2020    Key Record Dates
Last Update Posted: May 4, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No